Shane Barton - Dec 18, 2024 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Principal Accounting Officer
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Stock symbol
BIOA
Transactions as of
Dec 18, 2024
Transactions value $
$0
Form type
4
Date filed
12/20/2024, 04:04 PM
Previous filing
Sep 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOA Stock Option (Right to Buy) Award $0 +40K $0.00 40K Dec 18, 2024 Common Stock 40K $4.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest as to 1/48th of the total award monthly, with the first tranche vesting on October 26, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.